Salmonellosis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: SLM003 MIFTS: 55	Salmonellosis Categories: Infectious diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs Download Expand all tables

Sources

Aliases & Classifications for Salmonellosis

MalaCards integrated aliases for Salmonellosis:

Name: Salmonellosis ¹² ⁷⁶ ³ ¹⁵ ⁷³

Salmonella Infections ⁵⁵ ⁴³ ⁷³

Salmonella Infection ¹²

Classifications:

MalaCards categories:
Global: Infectious diseases

See all MalaCards categories (disease lists)

ICD10: ³³

Certain infectious and parasitic diseases

Intestinal infectious diseases

Other salmonella infections

Other specified salmonella infections

Salmonella enteritis

External Ids:

Disease Ontology ¹² DOID:0060859

ICD10 ³³ A02.0 A02.8

ICD9CM ³⁵ 003.0

UMLS ⁷³ C0036117 C2945607

Sources

Summaries for Salmonellosis

MedlinePlus : ⁴³ Salmonella is the name of a group of bacteria. In the United States, it is a common cause of foodborne illness. Salmonella occurs in raw poultry, eggs, beef, and sometimes on unwashed fruit and vegetables. You also can get infected after handling pets, especially reptiles like snakes, turtles, and lizards. Symptoms include Fever Diarrhea Abdominal cramps Headache Possible nausea, vomiting, and loss of appetite Symptoms usually last 4-7 days. Your health care provider diagnoses the infection with a stool test. Most people get better without treatment. Infection can be more serious in the elderly, infants, and people with chronic health problems. If Salmonella gets into the bloodstream, it can be serious. The usual treatment is antibiotics. Typhoid fever, a more serious disease caused by Salmonella, is not common in the United States. It frequently occurs in developing countries. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Salmonellosis, also known as salmonella infections, is related to typhoid fever and schistosomiasis, and has symptoms including fever and pruritus. An important gene associated with Salmonellosis is IL12RB1 (Interleukin 12 Receptor Subunit Beta 1), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Azithromycin and Cefixime have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and liver, and related phenotypes are hematopoietic system and cellular

Disease Ontology : ¹² A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has sypmtoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment.

CDC : ³ CDC estimates Salmonella causes about 1.2 million illnesses, 23,000 hospitalizations, and 450 deaths in the United States every year. Food is the source for about 1 million of these illnesses.

Wikipedia : ⁷⁶ Salmonellosis is a symptomatic infection caused by bacteria of the Salmonella type. The most common... more...

Sources

Related Diseases for Salmonellosis

Diseases related to Salmonellosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)

#	Related Disease	Score	Top Affiliating Genes
1	typhoid fever	30.4	ALB CASP1 IFNG IFNGR1 IL1B SLC11A1
2	schistosomiasis	30.4	ALB IFNG IFNGR1
3	brucellosis	30.2	IFNG SLC11A1 TLR4
4	chagas disease	30.0	IFNG IL1B TLR4
5	pneumonia	29.9	IL1B LACTB TLR4
6	acquired immunodeficiency syndrome	29.9	ALB IFNG IL1B
7	cysticercosis	29.7	IL18 IL1B TLR4
8	crohn's disease	29.6	IL1B SLC11A1 TLR4
9	campylobacteriosis	29.3	IFNG IL1B JUN SLC11A1 STAT1 TLR4
10	lymphadenitis	28.0	IFNG IFNGR1 IL12RB1 IL18 IL1B SLC11A1
11	malaria	27.2	ALB CASP1 IFNG IFNGR1 IL18 IL1B
12	invasive non-typhoidal salmonellosis	12.0
13	immunodeficiency 30	11.2
14	immunodeficiency 27b	11.1
15	immunodeficiency 29	11.0
16	immunodeficiency 27a	10.9
17	interferon gamma, receptor 1, deficiency	10.9	IFNG IFNGR1
18	axillary adenitis	10.8	IL12RB1 STAT1
19	prosthetic joint infection	10.8	IL1B TLR4
20	variola major	10.8	IFNG TLR4
21	mycobacterium fortuitum	10.7	IFNGR1 IL12RB1 LACTB
22	macs syndrome	10.7	IFNGR1 IL12RB1 SLC11A1
23	staphylococcal toxic shock syndrome	10.7	IFNG IL1B
24	autoimmune myocarditis	10.7	IFNG IL1B
25	abdominal tuberculosis	10.6	ALB IL12RB1
26	coccidioidomycosis	10.6	IFNGR1 STAT1 TLR4
27	penicillin allergy	10.6	IFNG IFNGR1
28	q fever	10.5	IFNG IL1B TLR4
29	extrapulmonary tuberculosis	10.5	IFNG IL1B SLC11A1
30	bacterial vaginosis	10.5	DEFB4A IL1B TLR4
31	gastrointestinal tuberculosis	10.5	ALB IFNG
32	septic arthritis	10.5	DEFB4A IFNG TLR4
33	toxoplasmosis	10.5	IFNG IL1B TLR4
34	toxic shock syndrome	10.5	IFNG IL1B TLR4
35	meningitis and encephalitis	10.5	ALB CP
36	eumycotic mycetoma	10.5	DEFB4A IFNG IL1B
37	aggressive periodontitis	10.5	DEFB1 IL1B TLR4
38	immune deficiency disease	10.5	IFNG IFNGR1 IL12RB1
39	tonsillitis	10.4	DEFB1 IFNG IL1B
40	vulvovaginal candidiasis	10.4	DEFB1 DEFB4A IFNG
41	pyelonephritis	10.4	ALB IL1B TLR4
42	burns	10.4	ALB IL1B
43	periodontitis	10.4	IFNG IL1B TLR4
44	filariasis	10.4	ALB IFNG TLR4
45	eales disease	10.4	CP IFNG IL1B
46	mouth disease	10.4	IFNG IL1B STAT1
47	hypersensitivity reaction disease	10.3	ALB IFNG IL1B
48	chronic inflammatory demyelinating polyradiculoneuropathy	10.3	ALB IFNG STAT1
49	systemic onset juvenile idiopathic arthritis	10.3	IL18 IL1B
50	trypanosomiasis	10.3	ALB IFNG IL1B

Comorbidity relations with Salmonellosis via Phenotypic Disease Network (PDN):

Acute Cystitis

Graphical network of the top 20 diseases related to Salmonellosis:

Sources

Symptoms & Phenotypes for Salmonellosis

UMLS symptoms related to Salmonellosis:

fever, pruritus

MGI Mouse Phenotypes related to Salmonellosis:

⁴⁶ (show all 12)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hematopoietic system	MP:0005397	10.27	CP IL12RB1 IL18 NLRC4 TLR4 IFNG
2	cellular	MP:0005384	10.24	JUN STAT1 CP NLRC4 IL18 IFNG
3	immune system	MP:0005387	10.22	CP IL12RB1 IL18 NLRC4 TLR4 IFNG
4	homeostasis/metabolism	MP:0005376	10.21	JUN STAT1 CP IL12RB1 IL18 IFNG
5	cardiovascular system	MP:0005385	10.16	IFNGR1 JUN STAT1 CP IL18 IFNG
6	digestive/alimentary	MP:0005381	10.08	STAT1 IL18 TLR4 SLC11A1 IFNG ALB
7	mortality/aging	MP:0010768	10	CASP1 IFNGR1 JUN STAT1 SLC11A1 IL18
8	integument	MP:0010771	9.97	IFNGR1 JUN STAT1 IL18 IFNG IL1B
9	liver/biliary system	MP:0005370	9.92	CP TLR4 IFNG ALB SPI1 IFNGR1
10	neoplasm	MP:0002006	9.81	TLR4 IFNG SLC11A1 ALB SPI1 IL1B
11	nervous system	MP:0003631	9.65	IFNGR1 JUN STAT1 CP IL18 IFNG
12	vision/eye	MP:0005391	9.17	JUN STAT1 CP IL18 IFNG SPI1

Sources

Drugs & Therapeutics for Salmonellosis

Drugs for Salmonellosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 44)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Azithromycin

Approved

Phase 4

83905-01-5

55185 447043

Cefixime

Approved, Investigational

Phase 4

79350-37-1

54362 5362065

Ceftriaxone

Approved

Phase 4,Not Applicable

73384-59-5

5479530 5361919

Gatifloxacin

Approved, Investigational

Phase 4

112811-59-3

5379

Anti-Bacterial Agents

Phase 4,Not Applicable

Antibiotics, Antitubercular

Phase 4

Anti-Infective Agents

Phase 4,Phase 1,Phase 2,Not Applicable

Antitubercular Agents

Phase 4

Vaccines

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Fluoroquinolones

Phase 4

Nucleic Acid Synthesis Inhibitors

Phase 4

Topoisomerase Inhibitors

Phase 4

Lactitol

Investigational

Phase 3,Phase 2

585-86-4

3871

Albendazole

Approved, Vet_approved

Phase 1, Phase 2

54965-21-8

2082

Metronidazole

Approved

Phase 1, Phase 2

443-48-1

4173

Secnidazole

Approved

Phase 1, Phase 2

3366-95-8

Zinc

Approved, Investigational

Phase 1, Phase 2

7440-66-6

23994

Zinc sulfate

Approved, Investigational

Phase 1, Phase 2

7733-02-0

Formaldehyde

Approved, Vet_approved

Phase 2

50-00-0

712

Vitamin A

Approved, Nutraceutical, Vet_approved

Phase 2

11103-57-4, 68-26-8

445354

Heptavalent Pneumococcal Conjugate Vaccine

Phase 2

Pharmaceutical Solutions

Phase 1, Phase 2,Not Applicable

Anthelmintics

Phase 1, Phase 2

Antimitotic Agents

Phase 1, Phase 2

Antiparasitic Agents

Phase 1, Phase 2

Antiprotozoal Agents

Phase 1, Phase 2

Astringents

Phase 1, Phase 2

Dermatologic Agents

Phase 1, Phase 2

Micronutrients

Phase 1, Phase 2

Trace Elements

Phase 1, Phase 2

Antibodies

Phase 2,Not Applicable

Immunoglobulins

Phase 2,Not Applicable

Retinol palmitate

Phase 2

retinol

Nutraceutical

Phase 2

Loperamide

Approved

Phase 1

53179-11-6

3955

Pectin

Approved, Investigational, Vet_approved

Phase 1

9000-69-5

441476

Antidiarrheals

Phase 1

Gastrointestinal Agents

Phase 1

Amoxicillin

Approved, Vet_approved

Not Applicable

26787-78-0

33613

Ampicillin

Approved, Vet_approved

Not Applicable

69-53-4

6249

Infliximab

Approved

170277-31-3

Disinfectants

Ether

Antirheumatic Agents

Interventional clinical trials:

(show all 42)

#	Name	Status	NCT ID	Phase	Drugs
1	Typhoid Fever: Combined vs. Single Antibiotic Therapy	Unknown status	NCT02224040	Phase 4	ceftriaxone;ceftriaxone and azithromycin;azithromycin;azithromycin and cefixime
2	Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood	Completed	NCT00125047	Phase 4
3	Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China	Completed	NCT00131833	Phase 4
4	Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam	Completed	NCT00131820	Phase 4
5	Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever	Completed	NCT01421693	Phase 4	Ceftriaxone;Gatifloxacin
6	Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever	Completed	NCT00125008	Phase 4
7	Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort	Enrolling by invitation	NCT03312699	Phase 4
8	Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects	Completed	NCT01608815	Phase 3
9	A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults	Completed	NCT01466387	Phase 3
10	Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi	Recruiting	NCT03299426	Phase 3
11	Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults	Completed	NCT01438996	Phase 2
12	Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants	Completed	NCT01437267	Phase 2
13	Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants	Completed	NCT01229176	Phase 2
14	Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)	Completed	NCT01193907	Phase 2
15	Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults	Completed	NCT00679172	Phase 2
16	TY800 Dose Escalation (Typhoid)	Completed	NCT00269295	Phase 1, Phase 2	Placebo
17	Studies of Immune Responses to Orally Administered Vaccines in Developing Country	Completed	NCT01019083	Phase 1, Phase 2	Placebo;Placebo;Zinc Sulphate;Albendazole and Secnidazole
18	Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects	Completed	NCT00498654	Phase 2
19	Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants	Completed	NCT00342628	Phase 2
20	Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine	Recruiting	NCT03527355	Phase 2
21	Vaccines Against Salmonella Typhi	Active, not recruiting	NCT02324751	Phase 2
22	Understanding Typhoid Disease After Vaccination	Active, not recruiting	NCT01405521	Phase 2
23	Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine	Completed	NCT02645032	Phase 1
24	Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)	Completed	NCT01123941	Phase 1
25	CVD 909 Vi Prime Boost Study	Completed	NCT00326443	Phase 1	Placebo
26	Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine	Completed	NCT00277147	Phase 1	BB IND 6989
27	Reservoir of Invasive Salmonellosis in Children, DRC	Completed	NCT03073707
28	Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients	Completed	NCT00002052	Not Applicable	Ceftriaxone sodium;Ampicillin sodium;Amoxicillin trihydrate
29	NCCLS Interpretive Criteria for Salmonella	Completed	NCT00177658
30	Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders	Completed	NCT02105714
31	Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers	Completed	NCT02628054	Not Applicable
32	Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers	Completed	NCT02391909
33	Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age	Completed	NCT00386789
34	Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)	Completed	NCT00705614
35	Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)	Completed	NCT01766830	Not Applicable
36	Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission	Recruiting	NCT03494101
37	IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres	Recruiting	NCT02689193
38	Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India	Recruiting	NCT03554213
39	Global Genomic and Proteomic Profiling of African Children With Typhoid Fever	Recruiting	NCT02947295
40	Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study	Recruiting	NCT02192008	Not Applicable
41	Investigating Typhoid Fever Pathogenesis	Active, not recruiting	NCT03067961	Not Applicable
42	Understanding Paratyphoid Infection	Active, not recruiting	NCT02100397	Not Applicable

Search NIH Clinical Center for Salmonellosis

Inferred drug relations via UMLS ⁷³ / NDF-RT ⁵¹ :

chloramphenicol sodium succinate

Sources

Genetic Tests for Salmonellosis

Sources

Anatomical Context for Salmonellosis

MalaCards organs/tissues related to Salmonellosis:

⁴¹

Testes, T Cells, Liver, Colon, Lymph Node, Neutrophil, Ovary

Sources

Publications for Salmonellosis

Articles related to Salmonellosis:

(show top 50) (show all 626)

#	Title	Authors	Year
1	Potent O-antigen-deficient (rough) mutants of Salmonella Typhimurium secreting Lawsonia intracellularis antigens enhance immunogenicity and provide single-immunization protection against proliferative enteropathy and salmonellosis in a murine model. ( 29976253 )	Park S....Lee J.H.	2018
2	Municipal Wastewater as a Microbial Surveillance Platform for Enteric Diseases: A Case Study for Salmonella and Salmonellosis. ( 29630348 )	Yan T....Pagaling E.	2018
3	Incubation period for outbreak-associated, non-typhoidal salmonellosis cases, Minnesota, 2000-2015. ( 29409557 )	Eikmeier D....Smith K.	2018
4	Diagnosis and Treatment of Human Salmonellosis in Addis Ababa City, Ethiopia. ( 29951540 )	Garedew L....Erenso G.	2018
5	International Symposium on Salmonella and salmonellosis. ( 29366459 )	Colin P.	2018
6	Novel Salmonella enterica Serovar Typhimurium Genotype Levels as Herald of Seasonal Salmonellosis Epidemics. ( 29774859 )	Sotomayor C....Sintchenko V.	2018
7	Climate variability and salmonellosis in Singapore - A time series analysis. ( 29929293 )	Aik J....Turner R.	2018
8	Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review. ( 29701663 )	Chlebicz A....A9liA1ewska K.	2018
9	A Quantitative Risk Assessment of Human Salmonellosis from Consumption of Pistachios in the United States. ( 29757010 )	Farakos S.M.S....Doren J.M.V.	2018
10	Risk Assessment of Salmonellosis from Consumption of Alfalfa Sprouts and Evaluation of the Public Health Impact of Sprout Seed Treatment and Spent Irrigation Water Testing. ( 29341180 )	Chen Y....Van Doren J.M.	2018
11	<i>Salmonella</i> and salmonellosis in horses: an overview. ( 29884637 )		2018
12	Looking for new approaches for the use of serology in the context of control programmes against pig salmonellosis. ( 29218859 )	Mainar-Jaime R.C....Vico J.P.	2018
13	A Quantitative Assessment of the Risk of Human Salmonellosis Arising from the Consumption of Pecans in the United States. ( 28812908 )	Farakos S.M.S....Doren J.M.V.	2017
14	Using Microsimulation to Estimate the Future Health and Economic Costs of Salmonellosis under Climate Change in Central Queensland, Australia. ( 29233795 )	Stephen D.M....Barnett A.G.	2017
15	Highly suspected cases of salmonellosis in two cats fed with a commercial raw meat-based diet: health risks to animals and zoonotic implications. ( 28738871 )	Giacometti F....Piva S.	2017
16	Risk of Salmonellosis from Chicken Parts Prepared from Whole Chickens Sold in Flow Pack Wrappers and Subjected to Temperature Abuse. ( 28800246 )	Oscar T.P.	2017
17	Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020. ( 28935025 )	Maertens de Noordhout C....Speybroeck N.	2017
18	Importation of travel-related infectious diseases is increasing in South Korea: An analysis of salmonellosis, shigellosis, malaria, and dengue surveillance data. ( 28919170 )	Choe Y.J....Cho S.I.	2017
19	Impact of Clinical Salmonellosis in Veal Calves on the Recovery of Salmonella in Lymph Nodes at Harvest. ( 28910140 )	MuA+oz-Vargas L....Habing G.	2017
20	CXCR3 plays a critical role for host protection against Salmonellosis. ( 28860493 )	Chami B....Bao S.	2017
21	CASE SERIES: CLINICAL SALMONELLOSIS IN FOUR BLACK RHINOCEROS (DICEROS BICORNIS) CALVES. ( 28749277 )	Love D....Lung N.P.	2017
22	Review of egg-related salmonellosis and reduction strategies in United States, Australia, United Kingdom and New Zealand. ( 28903617 )	Chousalkar K....Pande V.	2017
23	Immune-Stimulatory and Therapeutic Activity of<i>Tinospora cordifolia</i>: Double-Edged Sword against Salmonellosis. ( 29318160 )	Alsuhaibani S....Khan M.A.	2017
24	Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice. ( 28702137 )	Nikkhahi F....Torabi Bonab P.	2017
25	Clinical Salmonellosis in a Closed Colony of Blood Donor Cats. ( 29212585 )	Koenig A....Sakamoto K.	2017
26	Water Quality Survey of Splash Pads After A Waterborne Salmonellosis Outbreak--Tennessee, 2014. ( 29154527 )	Clayton J.L....Jones T.F.	2017
27	Small animal disease surveillance: GI disease and salmonellosis. ( 28864509 )	Arsevska E....Davies R.H.	2017
28	Extraintestinal Salmonellosis in the Immunocompromised: An Unusual Case of Pyomyositis. ( 29081808 )	Meyyur Aravamudan V....Tambyah P.A.	2017
29	Disseminated Mycobacterium malmoense and Salmonella Infections Associated with a Novel Variant in NFKBIA. ( 28417298 )	Staples E....Thaventhiran J.E.D.	2017
30	Different Age Distribution between Campylobacteriosis and Nontyphoidal Salmonellosis in Hospitalized Korean Children with Acute Inflammatory Diarrhea. ( 28581280 )	Shim J.O....Shin S.	2017
31	Turmeric Bioprocessed with Mycelia from the Shiitake Culinary-Medicinal Mushroom Lentinus edodes (Agaricomycetes) Protects Mice Against Salmonellosis. ( 28605325 )	Kim S.P....Friedman M.	2017
32	Gastric wall and splenic abscess in the background of an invasive salmonellosis caused by Salmonella enteritidis. ( 29150121 )	Toresano-LA^pez D....ArnA!iz-GarcA-a M.E.	2017
33	Salmonellosis beyond the gastrointestinal tract: a case series ( 29393612 )	Piyasiri D.L....Gamage T.S.	2017
34	Study of antimicrobial resistance and physiological biomarkers with special reference to Salmonellosis in diarrheic foals in Punjab, Pakistan. ( 28784420 )	Haq I....Ahmad I.	2017
35	An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013. ( 28264046 )	Keddy K.H....Angulo F.J.	2017
36	Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso. ( 28692655 )	Guiraud I....Jacobs J.	2017
37	Biosecurity aspects of cattle production in Western Uganda, and associations with seroprevalence of brucellosis, salmonellosis and bovine viral diarrhoea. ( 29212482 )	Wolff C....Sternberg-Lewerin S.	2017
38	Chronic Disseminated Salmonellosis in a Patient with Interleukin- 12p40 Deficiency. ( 28723869 )	Alaki E.M....Casanova J.L.	2017
39	Phenotypic and Molecular Characterization of Salmonella Enteritidis SE86 Isolated from Poultry and Salmonellosis Outbreaks. ( 29106298 )	Borges K.A....do Nascimento V.P.	2017
40	Occupational Distribution of Campylobacteriosis and Salmonellosis Cases - Maryland, Ohio, and Virginia, 2014. ( 28817554 )	Su C.P....Luckhaupt S.E.	2017
41	Understanding the effects of intermittent shedding on the transmission of infectious diseases: example of salmonellosis in pigs. ( 28929911 )	Lahodny G.E....Ivanek R.	2017
42	Multi-provincial Salmonellosis Outbreak Related to Newly Hatched Chicks and Poults: A Genomics Perspective. ( 29034124 )	Croxen M.A....King R.K.	2017
43	Modeling the risk of salmonellosis from consumption of pistachios produced and consumed in the United States. ( 28648297 )	Lambertini E....Harris L.J.	2017
44	A Syst-OMICS Approach to Ensuring Food Safety and Reducing the Economic Burden of Salmonellosis. ( 28626454 )	Emond-Rheault J.G....Levesque R.C.	2017
45	The type three secreted effector SipC regulates the trafficking of PERP during Salmonella infection. ( 27078059 )	Hallstrom K.N....McCormick B.A.	2016
46	Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis. ( 27660722 )	Amini V....Heidari H.	2016
47	Utilization of plant-derived recombinant human I^-defensins (hBD-1 and hBD-2) for averting salmonellosis. ( 25417183 )	Patro S....Dey N.	2015
48	Clinical features and outcome of typhoid fever and invasive non-typhoidal salmonellosis in a tertiary hospital in Belgium: analysis and review of the literature. ( 25819116 )	Yombi J.C....Robert A.	2015
49	Salmonella infective endocarditis. ( 25882489 )	Cheng W.L....Ko W.C.	2015
50	Community Incidence of Campylobacteriosis and Nontyphoidal Salmonellosis, France, 2008-2013. ( 26193045 )	van Cauteren D....Desenclos J.C.	2015

Sources

Genes for Salmonellosis

Genes related to Salmonellosis (0 elite genes):

(show all 17)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	IL12RB1	Interleukin 12 Receptor Subunit Beta 1	Protein Coding	39.37	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Disorders Publications (show sections)	9603733 11034424
2	IFNGR1	Interferon Gamma Receptor 1	Protein Coding	30.12	DISEASES inferred ¹⁵ GeneCards inferred via : Disorders Publications (show sections)
3	TLR4	Toll Like Receptor 4	Protein Coding	25.07	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	12595422 18975326
4	SLC11A1	Solute Carrier Family 11 Member 1	Protein Coding	24.34	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
5	IL1B	Interleukin 1 Beta	Protein Coding	22.51	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
6	CASP1	Caspase 1	Protein Coding	21.75	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : DISEASES inferred (show sections)	15528373 20160900 18667412
7	IL18	Interleukin 18	Protein Coding	21.59	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : DISEASES inferred (show sections)	11964842 15678889 12874316
8	IFNG	Interferon Gamma	Protein Coding	21.56	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
9	DEFB4A	Defensin Beta 4A	Protein Coding	21.07	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
10	DEFB1	Defensin Beta 1	Protein Coding	20.95	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
11	STAT1	Signal Transducer And Activator Of Transcription 1	Protein Coding	20.39	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
12	ALB	Albumin	Protein Coding	19.78	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
13	SPI1	Spi-1 Proto-Oncogene	Protein Coding	17.37	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
14	NLRC4	NLR Family CARD Domain Containing 4	Protein Coding	16.72	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
15	CP	Ceruloplasmin	Protein Coding	16.65	GeneCards inferred via : Publications (show sections)
16	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	16.65	GeneCards inferred via : Publications (show sections)
17	LACTB	Lactamase Beta	Protein Coding	12.28	Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	16918048

Sources

Variations for Salmonellosis

Sources

Expression for Salmonellosis

Search GEO for disease gene expression data for Salmonellosis.

Sources

Pathways for Salmonellosis

Pathways related to Salmonellosis according to GeneCards Suite gene sharing:

(show top 50) (show all 63)

#	Super pathways	Score	Top Affiliating Genes
1	Innate Immune System ⁶⁶ Show member pathways Immune System ⁶⁶ Neutrophil degranulation ⁶⁶	14.02	CASP1 DEFB1 DEFB4A IFNG IFNGR1 IL12RB1
2	PEDF Induced Signaling ⁶⁴ Show member pathways all-trans-Retinoic Acid Signaling in Brain ⁶⁴ Cytokine-cytokine receptor interaction ³⁷ Endothelin-1 Signaling Pathway ⁶⁴ Glucocorticoid Receptor Signaling ⁶⁴ IL-6 Pathway ⁶⁴ MIF Mediated Glucocorticoid Regulation ⁶⁴ MIF Regulation of Innate Immune Cells ⁶⁴ NFAT Signaling and Lymphocyte Interactions ⁶⁴ PGC1Alpha Pathway ⁶⁴ RAR-Gamma-RXR-Alpha Degradation ⁶⁴ STAT3 Pathway ⁶⁴	13.66	CASP1 IFNG IFNGR1 IL12RB1 IL18 IL1B
3	TGF-Beta Pathway ⁶⁴ Show member pathways JAK-STAT Pathway ⁶⁴ JNK Pathway ⁶⁴ MAPK Family Pathway ⁶⁴ Regulation of eIF4 and p70S6K ⁶⁴ SOCS Pathway ⁶⁴	13.49	IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
4	Cytokine Signaling in Immune system ⁶⁶ Show member pathways Signaling by Interleukins ⁶⁶	13.36	CASP1 IFNG IFNGR1 IL12RB1 IL18 IL1B
5	Toll-like Receptor Signaling Pathway ³⁷ ¹ Show member pathways Chagas disease (American trypanosomiasis) ³⁷ NOD-like receptor signaling pathway ³⁷ NOD-like Receptor Signaling Pathways ⁶⁵ Regulation of toll-like receptor signaling pathway ¹	12.96	CASP1 IFNG IFNGR1 IL18 IL1B JUN
6	Allograft rejection ¹ ³⁷ Show member pathways Antigen processing and presentation ³⁷ Asthma ³⁷ Autoimmune thyroid disease ³⁷ CTL Mediated Apoptosis ⁶⁴ Graft-versus-host disease ³⁷ Intestinal immune network for IgA production ³⁷ THC Differentiation Pathway ⁶⁴ Type I diabetes mellitus ³⁷ Viral myocarditis ³⁷	12.89	IFNG IFNGR1 IL12RB1 IL18 IL1B STAT1
7	Pathways in cancer ³⁷	12.84	IFNG IFNGR1 IL12RB1 JUN SPI1 STAT1
8	IL-2 Pathway ⁶⁴ Show member pathways HMGB1 Pathway ⁶⁴ LPS Stimulated MAPK Signaling ⁶⁴ PACAP Signaling ⁶⁴ PI3K Signaling in B-Lymphocyte ⁶⁴ TREM1 Pathway ⁶⁴	12.79	IFNG IFNGR1 IL1B JUN TLR4
9	Influenza A ³⁷ Show member pathways Herpes simplex infection ³⁷ Measles ³⁷	12.79	CASP1 IFNG IFNGR1 IL18 IL1B JUN
10	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways ⁶⁶ Show member pathways Cytosolic DNA-sensing pathway ³⁷ Immune response TLR3 and TLR4 induce TICAM1-specific signaling pathway ²² Negative regulators of RIG-I/MDA5 signaling ⁶⁶ NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 ⁶⁶ RIG-I-like Receptor Signaling ¹ RIG-I-like receptor signaling pathway ³⁷ TRAF3-dependent IRF activation pathway ⁶⁶ TRAF6 mediated IRF7 activation ⁶⁶ Virus Detection and Induction of Antiviral Signaling Pathways by RIG-I-like Receptors (RLR) ⁶⁵	12.76	CASP1 IFNG IL18 IL1B TLR4
11	4-1BB Pathway ⁶⁴ Show member pathways CD27 Pathway ⁶⁴ CD40 Signaling ⁶⁴ CMV and MAPK Pathways ⁶⁴ NF-KappaB Activation by EBV ⁶⁴ NF-kappaB Activation by Viruses ⁶⁴ PKR Pathway ⁶⁴ SUMO Pathway ⁶⁴ TNFR2 Pathway ⁶⁴	12.67	IFNG IFNGR1 IL1B JUN STAT1
12	Regulation of IFNA signaling ⁶⁶ Show member pathways Cytokine Network ⁶⁴ Immune response IFN alpha/beta signaling pathway ²² Interferon alpha/beta signaling ⁶⁶ Interleukin-19, 20, 22, 24 ⁶⁶ Jak/STAT Signaling Pathway ⁶⁵ Jak-STAT signaling pathway ³⁷	12.67	IFNG IFNGR1 IL12RB1 IL18 IL1B STAT1
13	Immune response IL-23 signaling pathway ²² Show member pathways Angiopoietin receptor Tie2-mediated signaling ¹ Angiopoietin-TIE2 Signaling ⁶⁴ Development Angiopoietin - Tie2 signaling ²² Development PDGF signaling via STATs and NF-kB ²² IL23-mediated signaling events ¹ Immune response IL-10 signaling pathway ²² Rac1/Pak1/p38/MMP-2 pathway ¹	12.6	IFNG IL12RB1 IL18 IL1B STAT1
14	Kaposi's sarcoma-associated herpesvirus infection ³⁷ Show member pathways Hepatitis B ³⁷	12.55	IFNGR1 JUN STAT1 TLR4
15	NF-kappaB Signaling ⁴	12.54	IFNG IL1B SPI1 STAT1
16	TRAF Pathway ⁶⁴ Show member pathways 14-3-3 Induced Apoptosis ⁶⁴ TNF Superfamily Pathway ⁶⁴ Toll-Like Receptors Pathway ⁶⁴	12.52	CASP1 IL1B JUN TLR4
17	IL-17 Family Signaling Pathways ⁶⁵ Show member pathways IL17 signaling pathway ¹ IL-17 signaling pathway ³⁷ Interleukin-17 signaling ⁶⁶ Mucin expression in CF via IL-6, IL-17 signaling pathways ²²	12.34	DEFB4A IFNG IL1B JUN
18	Toxoplasmosis ³⁷ Show member pathways Leishmaniasis ³⁷	12.3	IFNG IFNGR1 IL1B JUN STAT1 TLR4
19	IL-1 Family Signaling Pathways ⁶⁵ Show member pathways Immune response IL-1 signaling pathway ²² Mucin expression in CF via TLRs, EGFR signaling pathways ²²	12.26	CP IL18 IL1B JUN STAT1
20	Tuberculosis ³⁷	12.25	IFNG IFNGR1 IL18 IL1B STAT1 TLR4
21	C-type lectin receptor signaling pathway ³⁷ Show member pathways Pathogen or Damage-activated C-Type Lectin Receptor Signaling Pathways ⁶⁵	12.23	CASP1 IL1B JUN STAT1
22	Necroptosis ³⁷ Show member pathways Nanoparticle triggered regulated necrosis ¹	12.23	CASP1 IFNG IFNGR1 IL1B STAT1 TLR4
23	Colorectal Cancer Metastasis ⁶⁴	12.2	IFNG IFNGR1 STAT1 TLR4
24	Th17 cell differentiation ³⁷ Show member pathways Inflammatory bowel disease (IBD) ³⁷ Th1 and Th2 cell differentiation ³⁷	12.18	IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
25	Toll Comparative Pathway ⁶⁴ Show member pathways IL-1 Pathway ⁶⁴ Immune response MIF in innate immunity response ²² iNOS Signaling ⁶⁴ TLR-TRIF Pathway ⁶⁴	12.16	IFNG IFNGR1 IL1B JUN SPI1 STAT1
26	Immune response Antigen presentation by MHC class II ²² Show member pathways G-protein signaling N-RAS regulation pathway ²² IL-22 Pathway ⁶⁴ Immune response IL-22 signaling pathway ²²	12.14	IL12RB1 JUN STAT1
27	Immune response IFN gamma signaling pathway ²² Show member pathways IFN-gamma pathway ¹	12.11	CASP1 IFNG IFNGR1 IL18 IL1B JUN
28	MAPK Pathway ⁷² Show member pathways Toll-like Receptor Pathway ⁷²	12.05	IL1B JUN STAT1 TLR4
29	Osteoclast differentiation ³⁷	12.02	IFNG IFNGR1 IL1B JUN SPI1 STAT1
30	Bacterial infections in CF airways ²² Show member pathways IL-1 beta-dependent CFTR expression ²² Immune response Bacterial infections in normal airways ²² Immune response TLR signaling pathways ²²	12.02	DEFB4A IFNG IFNGR1 IL1B JUN STAT1
31	Spinal Cord Injury ¹	11.99	IFNG IL1B TLR4
32	Interleukin-4 and 13 signaling ⁶⁶	11.96	IL18 IL1B STAT1
33	IL12-mediated signaling events ¹ Show member pathways Immune response IL-12-induced IFN-gamma production ²²	11.93	IFNG IL12RB1 IL18 IL1B JUN STAT1
34	Senescence and Autophagy in Cancer ¹	11.92	IFNG IL1B JUN
35	Jak-Stat Signaling Pathway ⁶⁷	11.92	IFNG IFNGR1 IL12RB1 STAT1
36	Rheumatoid arthritis ³⁷	11.92	IFNG IL18 IL1B JUN TLR4
37	HIF-1 signaling pathway ³⁷	11.9	IFNG IFNGR1 TLR4
38	AGE-RAGE signaling pathway in diabetic complications ³⁷	11.89	IL1B JUN STAT1
39	Amoebiasis ³⁷	11.87	IFNG IL1B TLR4
40	Glucocorticoid receptor regulatory network ¹	11.84	IFNG JUN SPI1 STAT1
41	Innate Lymphoid Cell Differentiation Pathways ⁶⁵	11.84	IFNG IL12RB1 IL18 IL1B SPI1
42	Th1 Differentiation Pathway ⁶⁵ Show member pathways IL27-mediated signaling events ¹ IL-6-type cytokine receptor ligand interactions ⁶⁶ Interleukin-6 family signaling ⁶⁶ Interleukin-6 signaling ⁶⁶ Th17 Differentiation Pathway ⁶⁵	11.83	IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
43	Pertussis ³⁷	11.8	CASP1 IL1B JUN TLR4
44	Dendritic Cells Developmental Lineage Pathway ⁶⁵	11.75	IFNG IL1B SPI1
45	Photodynamic therapy-induced NF-kB survival signaling ¹ Show member pathways Immune response MIF-mediated glucocorticoid regulation ²²	11.67	IFNG IL1B JUN
46	TGF-beta Receptor Signaling (WikiPathways) ¹	11.63	IFNG JUN STAT1
47	Legionellosis ³⁷	11.62	CASP1 IL18 IL1B NLRC4 TLR4
48	Malaria ³⁷	11.6	IFNG IL18 IL1B TLR4
49	Cellular Transformation by HTLV1 ⁶⁴ Show member pathways Activation of NF-KappaB by PKR ⁶⁴	11.57	IFNG IFNGR1 JUN
50	MSP-RON Signaling ⁶⁴	11.57	IFNG IL18 IL1B TLR4

Sources

GO Terms for Salmonellosis

Cellular components related to Salmonellosis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular region	GO:0005576	9.56	ALB CASP1 CP DEFB1 DEFB4A IFNG
2	IPAF inflammasome complex	GO:0072557	8.62	CASP1 NLRC4

Biological processes related to Salmonellosis according to GeneCards Suite gene sharing:

(show all 35)

#	Name	GO ID	Score	Top Affiliating Genes
1	inflammatory response	GO:0006954	9.96	IL18 IL1B NLRC4 SLC11A1 TLR4
2	positive regulation of gene expression	GO:0010628	9.95	IFNG IL18 IL1B SLC11A1 TLR4
3	cellular response to interferon-gamma	GO:0071346	9.83	CASP1 IL12RB1 STAT1
4	defense response to bacterium	GO:0042742	9.8	DEFB1 DEFB4A NLRC4 SLC11A1 TLR4
5	cellular response to mechanical stimulus	GO:0071260	9.79	CASP1 IL1B TLR4
6	cellular response to organic cyclic compound	GO:0071407	9.79	IL18 IL1B STAT1
7	interferon-gamma-mediated signaling pathway	GO:0060333	9.77	IFNG IFNGR1 STAT1
8	response to lipopolysaccharide	GO:0032496	9.77	CASP1 IL1B JUN SLC11A1 TLR4
9	positive regulation of smooth muscle cell proliferation	GO:0048661	9.75	IL18 JUN STAT1
10	antimicrobial humoral response	GO:0019730	9.74	DEFB1 DEFB4A SLC11A1
11	defense response to Gram-negative bacterium	GO:0050829	9.73	DEFB1 DEFB4A SLC11A1 TLR4
12	cytokine-mediated signaling pathway	GO:0019221	9.73	CASP1 IFNGR1 IL12RB1 IL18 IL1B STAT1
13	positive regulation of NIK/NF-kappaB signaling	GO:1901224	9.71	IL18 IL1B TLR4
14	immune response	GO:0006955	9.7	DEFB1 DEFB4A IFNG IL18 IL1B SLC11A1
15	response to ATP	GO:0033198	9.67	CASP1 IL1B
16	positive regulation of nitric oxide biosynthetic process	GO:0045429	9.67	IFNG IL1B TLR4
17	positive regulation of membrane protein ectodomain proteolysis	GO:0051044	9.66	IFNG IL1B
18	positive regulation of nitric-oxide synthase biosynthetic process	GO:0051770	9.66	STAT1 TLR4
19	positive regulation of interferon-alpha production	GO:0032727	9.65	STAT1 TLR4
20	interferon-gamma production	GO:0032609	9.65	IL18 TLR4
21	pyroptosis	GO:0070269	9.64	CASP1 NLRC4
22	negative regulation of interleukin-17 production	GO:0032700	9.64	IFNG TLR4
23	T-helper 1 type immune response	GO:0042088	9.63	IL18 TLR4
24	positive regulation of granulocyte macrophage colony-stimulating factor production	GO:0032725	9.63	IL18 IL1B
25	lipopolysaccharide-mediated signaling pathway	GO:0031663	9.63	IL18 IL1B TLR4
26	macrophage activation	GO:0042116	9.62	SLC11A1 TLR4
27	positive regulation of T-helper 1 type immune response	GO:0002827	9.61	IL12RB1 SLC11A1
28	interleukin-1 beta secretion	GO:0050702	9.59	NLRC4 TLR4
29	interleukin-6 production	GO:0032635	9.58	IL18 IL1B
30	interleukin-1 beta production	GO:0032611	9.51	CASP1 IL1B
31	regulation of interferon-gamma-mediated signaling pathway	GO:0060334	9.5	IFNG IFNGR1 STAT1
32	positive regulation of calcidiol 1-monooxygenase activity	GO:0060559	9.48	IFNG IL1B
33	response to bacterium	GO:0009617	9.26	CASP1 DEFB1 SLC11A1 TLR4
34	positive regulation of interferon-gamma production	GO:0032729	9.02	IL12RB1 IL18 IL1B SLC11A1 TLR4
35	positive regulation of transcription by RNA polymerase II	GO:0045944	10.07	IL18 IL1B JUN SLC11A1 SPI1 STAT1

Molecular functions related to Salmonellosis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	identical protein binding	GO:0042802	9.5	ALB CASP1 DEFB1 JUN LACTB NLRC4
2	CCR6 chemokine receptor binding	GO:0031731	9.16	DEFB1 DEFB4A
3	transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding	GO:0000982	8.8	JUN SPI1 STAT1

Sources

Sources for Salmonellosis

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia

Salmonellosis

Aliases & Classifications for Salmonellosis

MalaCards integrated aliases for Salmonellosis:

Classifications:

External Ids:

Summaries for Salmonellosis

Related Diseases for Salmonellosis

Diseases related to Salmonellosis via text searches within MalaCards or GeneCards Suite gene sharing:

Comorbidity relations with Salmonellosis via Phenotypic Disease Network (PDN):

Graphical network of the top 20 diseases related to Salmonellosis:

Symptoms & Phenotypes for Salmonellosis

UMLS symptoms related to Salmonellosis:

MGI Mouse Phenotypes related to Salmonellosis:

Drugs & Therapeutics for Salmonellosis

Drugs for Salmonellosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Inferred drug relations via UMLS 73 / NDF-RT 51 :

Genetic Tests for Salmonellosis

Anatomical Context for Salmonellosis

MalaCards organs/tissues related to Salmonellosis:

Publications for Salmonellosis

Articles related to Salmonellosis:

Genes for Salmonellosis

Genes related to Salmonellosis (0 elite genes):

Variations for Salmonellosis

Expression for Salmonellosis

Pathways for Salmonellosis

Pathways related to Salmonellosis according to GeneCards Suite gene sharing:

GO Terms for Salmonellosis

Cellular components related to Salmonellosis according to GeneCards Suite gene sharing:

Biological processes related to Salmonellosis according to GeneCards Suite gene sharing:

Molecular functions related to Salmonellosis according to GeneCards Suite gene sharing:

Sources for Salmonellosis

Inferred drug relations via UMLS ⁷³ / NDF-RT ⁵¹ :